search
Back to results

Cardioprotective Properties of Natural Anti-Platelet Activating Factor Extract From Winery By-products in Healthy Women (NAPE)

Primary Purpose

Platelet Aggregation and Inflammation

Status
Unknown status
Phase
Not Applicable
Locations
Greece
Study Type
Interventional
Intervention
Supplement
Placebo
Sponsored by
Harokopio University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Platelet Aggregation and Inflammation focused on measuring winery by-products, natural extract, postprandial study, platelet aggregation, anti-inflammatory, healthy women, Platelet-activating factor

Eligibility Criteria

25 Years - 45 Years (Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria:

  • Healthy
  • Females
  • BMI: 22-32 kg/m2

Exclusion Criteria:

  • Systematic medication
  • Chronic disease conditions
  • Specific dietary conditions (vegeterian, vegan...)
  • Eating disorders

Sites / Locations

  • Department of Nutrition-Dietetics, Harokopio UniversityRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

Supplement

Placebo

Arm Description

Ethanol-water extract of winery by-products

Maltodextrin-based placebo

Outcomes

Primary Outcome Measures

Effect on platelet aggregation
% Change of EC50 value of platelet aggregation against PAF
Effect on platelet aggregation
% Change of EC50 value of platelet aggregation against ADP
Effect on platelet aggregation
% Change of EC50 value of platelet aggregation against Collagen
Effect on inflammatory markers
Change in PAF biosynthetic enzymes activity (lyso-PAF AT)
Effect on inflammatory markers
Change in PAF biosynthetic enzymes activity (PAF-CPT)
Effect on inflammatory markers
Change in PAF levels Change in PAF degradation enzyme activity (Lp-PLA2) Change in PAF levels IL6
Effect on inflammatory markers
Change in PAF degradation enzyme activity (Lp-PLA2)
Effect on inflammatory markers
IL-6

Secondary Outcome Measures

Effect on classical biochemical markers
Total serum cholesterol
Effect on classical biochemical markers
LDL-cholesterol
Effect on classical biochemical markers
HDL-cholesterol
Effect on classical biochemical markers
TAG
Effect on classical biochemical markers
uric acid
Effect on classical biochemical markers
Glucose
Effect on classical biochemical markers
Insulin
Detection and estimation of extract compounds metabolites

Full Information

First Posted
June 15, 2020
Last Updated
June 17, 2020
Sponsor
Harokopio University
search

1. Study Identification

Unique Protocol Identification Number
NCT04436263
Brief Title
Cardioprotective Properties of Natural Anti-Platelet Activating Factor Extract From Winery By-products in Healthy Women
Acronym
NAPE
Official Title
Investigation of in Vivo Anti-inflammatory and Anti-platelet Mechanisms of Natural Extract by Modulating PAF Metabolism and Actions
Study Type
Interventional

2. Study Status

Record Verification Date
June 2020
Overall Recruitment Status
Unknown status
Study Start Date
January 20, 2020 (Actual)
Primary Completion Date
June 20, 2021 (Anticipated)
Study Completion Date
June 20, 2021 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Harokopio University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to investigate the anti-platelet and anti-inflammatory properties of a winery by-products extract as well as to detect extract compounds and their metabolites in biological fluids. The study is a randomized, double-blind, crossover, placebo controlled postprandial study in healthy women.
Detailed Description
The well-known cardioprotective and metabolic effects of wine consumption are mainly attributed to its micro-constituents. Grape pomace (GP) is a by-product of the winemaking process and consists mainly of skins and seeds. Winery by-products are a cheap and rich source of similar-to wine micro-constituents, which can be used either to enrich other foods or to be included in food supplements targeting the prevention or partially the therapy of cardiovascular diseases.In this line, our previous results revealed the potent in vitro anti-platelet effects of a specific ethanol-water extract rich in Platelet-Activating Factor inhibitors from winery by-products. The purpose of this study is to investigate the in vivo anti-platelet and anti-inflammatory properties of the specific winery by-products extract as well as to detect the extract compounds and their metabolites in biological fluids. Therefore a randomized double-blind, crossover, placebo controlled postprandial study in healthy women will be implemented. For this purpose, 15 healthy women will participate in the protocol. The two daily trials will take place during specific days based on their menstrual cycle. Three days before each blood collection the volunteers will be instructed to abstain from food and beverages rich in phenolic compounds and their dietary intake will be recorded (three 24h recalls and one food frequency questionnaire). The blood collections will be carried out after 8h fasting. At trial day, the volunteers will bring the first morning urine sample and anthropometric measurements will take place (weight, height, waist/hip circumference, bioelectrical impedance). Then a venous catheter will be placed and after 10 minutes the fasting blood will be collected. Volunteers will proceed to the consumption of a standardized meal (1131 kcal, 19.7% carbohydrates, 11.2% protein, 66.7% fat) along with the capsules (study extract or placebo). The type of the capsules consumed (study extract or placebo) will be randomized and blind during the two intervention days for both volunteers and investigators. Blood will be drown after the meal consumption and for the next 6h (every 30minutes for the first 4h and every 1h for the next 2h). Serum, plasma, platelet-rich plasma, leukocyte-rich plasma and urine samples will be isolated at certain time points during trial days so that the anti-platelet, anti-inflammatory and antioxidant effects of the study extract can be evaluated.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Platelet Aggregation and Inflammation
Keywords
winery by-products, natural extract, postprandial study, platelet aggregation, anti-inflammatory, healthy women, Platelet-activating factor

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
ParticipantCare ProviderInvestigator
Allocation
Randomized
Enrollment
15 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Supplement
Arm Type
Experimental
Arm Description
Ethanol-water extract of winery by-products
Arm Title
Placebo
Arm Type
Placebo Comparator
Arm Description
Maltodextrin-based placebo
Intervention Type
Behavioral
Intervention Name(s)
Supplement
Intervention Description
A sufficient quantity of the winery by-products will be extracted on an industrial scale and capsules will be produced, each one containing 110mg of phenolic compounds (gallic acid equivalents).Volunteers will consume 6 capsules along with a standardized meal (1131 kcal, 19.7% carbohydrates, 11.2% protein, 66.7% fat) and blood will be drown before the meal consumption and at specific time points for the next 6h
Intervention Type
Behavioral
Intervention Name(s)
Placebo
Intervention Description
A look-alike placebo containing maltodextrin will be prepared.Volunteers will consume 6 capsules along with a standardized meal (1131 kcal, 19.7% carbohydrates, 11.2% protein, 66.7% fat) and blood will be drown before the meal consumption and at specific time points for the next 6h
Primary Outcome Measure Information:
Title
Effect on platelet aggregation
Description
% Change of EC50 value of platelet aggregation against PAF
Time Frame
Change between timepoints (before meal consumption, 30min, 90min, 150min, 210min, 300min) of the 6hour trial and between the two different interventions
Title
Effect on platelet aggregation
Description
% Change of EC50 value of platelet aggregation against ADP
Time Frame
Change between timepoints (before meal consumption, 30min, 90min, 150min, 210min, 300min) of the 6hour trial and between the two different interventions
Title
Effect on platelet aggregation
Description
% Change of EC50 value of platelet aggregation against Collagen
Time Frame
Change between timepoints (before meal consumption, 30min, 90min, 150min, 210min, 300min) of the 6hour trial and between the two different interventions
Title
Effect on inflammatory markers
Description
Change in PAF biosynthetic enzymes activity (lyso-PAF AT)
Time Frame
Change between timepoints (before meal consumption, 60min, 120min, 180min, 210min, 240min, 300min, 360min) of the 6hour trial and between the two different interventions
Title
Effect on inflammatory markers
Description
Change in PAF biosynthetic enzymes activity (PAF-CPT)
Time Frame
Change between timepoints (before meal consumption, 60min, 120min, 180min, 210min, 240min, 300min, 360min) of the 6hour trial and between the two different interventions
Title
Effect on inflammatory markers
Description
Change in PAF levels Change in PAF degradation enzyme activity (Lp-PLA2) Change in PAF levels IL6
Time Frame
Change between timepoints (before meal consumption, 60min, 120min, 180min, 240min, 360min) of the 6hour trial and between the two different interventions
Title
Effect on inflammatory markers
Description
Change in PAF degradation enzyme activity (Lp-PLA2)
Time Frame
Change between timepoints (before meal consumption, 0min, 30min, 60min, 90min, 120min, 150min, 180min, 210min, 240min, 300min, 360min) of the 6hour trial and between the two different interventions
Title
Effect on inflammatory markers
Description
IL-6
Time Frame
Change between timepoints (before meal consumption, 0min, 30min, 60min, 90min, 120min, 150min, 180min, 210min, 240min, 300min, 360min) of the 6hour trial and between the two different interventions
Secondary Outcome Measure Information:
Title
Effect on classical biochemical markers
Description
Total serum cholesterol
Time Frame
Change between timepoints (before meal consumption, 0min, 30min, 60min, 90min, 120min, 150min, 180min, 210min, 240min, 300min, 360min) of the 6hour trial and between the two different interventions
Title
Effect on classical biochemical markers
Description
LDL-cholesterol
Time Frame
Change between timepoints (before meal consumption, 0min, 30min, 60min, 90min, 120min, 150min, 180min, 210min, 240min, 300min, 360min) of the 6hour trial and between the two different interventions
Title
Effect on classical biochemical markers
Description
HDL-cholesterol
Time Frame
Change between timepoints (before meal consumption, 0min, 30min, 60min, 90min, 120min, 150min, 180min, 210min, 240min, 300min, 360min) of the 6hour trial and between the two different interventions
Title
Effect on classical biochemical markers
Description
TAG
Time Frame
Change between timepoints (before meal consumption, 0min, 30min, 60min, 90min, 120min, 150min, 180min, 210min, 240min, 300min, 360min) of the 6hour trial and between the two different interventions
Title
Effect on classical biochemical markers
Description
uric acid
Time Frame
Change between timepoints (before meal consumption, 0min, 30min, 60min, 90min, 120min, 150min, 180min, 210min, 240min, 300min, 360min) of the 6hour trial and between the two different interventions
Title
Effect on classical biochemical markers
Description
Glucose
Time Frame
Change between timepoints (before meal consumption, 0min, 30min, 60min, 90min, 120min, 150min, 180min, 210min, 240min, 300min, 360min) of the 6hour trial and between the two different interventions
Title
Effect on classical biochemical markers
Description
Insulin
Time Frame
Change between timepoints (before meal consumption, 0min, 30min, 60min, 90min, 120min, 150min, 180min, 210min, 240min, 300min, 360min) of the 6hour trial and between the two different interventions
Title
Detection and estimation of extract compounds metabolites
Time Frame
Change between timepoints (before meal consumption, 60min, 120min, 240min, 360min) of the 6hour trial and between the two different interventions

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
25 Years
Maximum Age & Unit of Time
45 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Healthy Females BMI: 22-32 kg/m2 Exclusion Criteria: Systematic medication Chronic disease conditions Specific dietary conditions (vegeterian, vegan...) Eating disorders
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Elizabeth Fragopoulou, PhD
Phone
2109549249
Ext
0030
Email
efragop@hua.gr
Facility Information:
Facility Name
Department of Nutrition-Dietetics, Harokopio University
City
Athens
ZIP/Postal Code
17671
Country
Greece
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Elizabeth Fragopoulou, PhD
Phone
2109549249
Ext
0030
Email
efragop@hua.gr
First Name & Middle Initial & Last Name & Degree
Elizabeth Fragopoulou, PhD

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Cardioprotective Properties of Natural Anti-Platelet Activating Factor Extract From Winery By-products in Healthy Women

We'll reach out to this number within 24 hrs